Mucus hypersecretion is a prominent manifestation in patients with chronic inflammatory airway diseases. MUC5AC mucin is a major component of airway mucus, and its expression is modulated by a TNF-␣-converting enzyme (TACE)-EGF receptor pathway that can be activated by reactive oxygen species (ROS). Dual oxidase 1 (Duox1), a homologue of glycoprotein p91 phox , is expressed in airway epithelium and generates ROS. We hypothesize that Duox1 activates TACE, cleaving pro-TGF-␣ into soluble TGF-␣, resulting in mucin expression. To examine this hypothesis, we stimulated both normal human bronchial epithelial cells and NCI-H292 airway epithelial cells with phorbol 12-myristate 13-acetate and with human neutrophil elastase. These stimuli induced TACE activation, TGF-␣ release, and mucin expression, effects that were inhibited by ROS scavengers, implicating ROS in TACE activation. Inhibition of epithelial NADPH oxidase or knockdown of Duox1 expression with small interfering RNA prevented ROS generation, TGF-␣ release, and mucin expression by these stimuli, implicating Duox1 in TACE activation and mucin expression. Furthermore, the PKC␦͞PKC inhibitor rottlerin prevented the effects induced by phorbol 12-myristate 13-acetate and human neutrophil elastase, suggesting that PKC␦ and PKC are involved in Duox1 activation. From these results, we conclude that Duox1 plays a critical role in mucin expression by airway epithelial cells through PKC␦͞PKC-Duox1-ROS-TACE-pro-ligand-EGF receptor cascade.
C
hronic inflammatory airway diseases are associated with mucus hypersecretion (1) , which contributes to the morbidity and mortality of these diseases by plugging airways. MUC5AC mucin is a major component of airway mucus, and its expression is modulated by TNF-␣-converting enzyme (TACE)-mediated EGF receptor (EGFR) transactivation; activated TACE cleaves EGFR proligand pro-TGF-␣ into soluble TGF-␣, which binds to and activates EGFR, resulting in MUC5AC mucin expression (2) (3) (4) .
Airway epithelial cells produce reactive oxygen species (ROS) (5) . There is increasing evidence showing that ROS are involved in cell signaling (6) . Recently, ROS scavengers have been shown to prevent cigarette-smoke-induced TACE activation, EGFR phosphorylation, and mucin production in airway epithelial cells (4) , implicating ROS in the activation of the TACE-EGFR pathway.
ROS have long been known to be generated by NADPH oxidase (Nox) of phagocytes (Phox) (7) . The core component of Nox is the catalytic subunit glycoprotein p91 phox (8) . Recently, a homologue of the gp91 phox , dual oxidase 1 (Duox1), was identified in human airway epithelial cells and shown to generate ROS (9, 10) . We hypothesize that Duox1 activates TACE via ROS generation, cleaving pro-TGF-␣ into soluble TGF-␣, resulting in EGFR activation and mucin expression. To examine this hypothesis, we stimulated normal human bronchial epithelial (NHBE) cells and NCI-H292 airway epithelial cells with phorbol 12-myristate 13-acetate (PMA) and human neutrophil elastase (HNE) . PMA is a model inflammatory stimulus known to induce mucin via TACE-EGFR pathway in NCI-H292 airway epithelial cells (2) , but the mechanism of activation of this pathway is unknown. HNE is a serine protease secreted by neutrophils and exists in high concentrations (1-20 M) (11, 12) in the airway surface fluid of patients with chronic inflammatory airway diseases. HNE is known to cause mucin production via TGF-␣-dependent EGFR activation (13) , but it is unknown how this process is initiated. Here, we show that PMA and HNE activate Duox1 to produce ROS, activating TACE, which cleaves pro-TGF-␣ into soluble TGF-␣, resulting in mucin expression in human airway epithelial cells.
Materials and Methods
Materials. Allopurinol, 1,3-dimethyl-2-thiourea (DMTU), npropyl gallete (nPG), and PMA were purchased from Sigma. Apocynin, diphenyleneiodonium chloride (DPI), Gö6983, Gö6976, N G -monoethyl-L-arginine, and rottlerin were purchased from Calbiochem. Monoclonal p47 phox and rabbit polyclonal p67 phox antibodies were purchased from Santa Cruz Biotechnology. HNE was purchased from Elastin Products (St. Louis).
Cell Culture. Proliferating NHBE cells were purchased from Cambrex (Walkersville, MD). When cells reached 80% confluence, they were seeded at density of 2 ϫ 10 4 per cm 2 onto Costar transwell plate inserts (Fisher), growing in bronchial epithelial growth medium (Cambrex) supplemented with defined growth factors and retinoic acid (0.1 g͞liter) contained in the SingleQuot kit (Cambrex) at 37°C in a humidified, 5% CO 2 ͞95% air, water-jacketed incubator. After 7 days in an immersed culture condition, cell culture was switched to an air-liquid interface condition for 2-3 weeks.
NCI-H292 airway epithelial cells were cultured as described in ref. 2 . After the cells reached confluence, they were serumstarved for 24 h before experiments to maintain low basal levels of MUC5AC expression.
Culture Conditions of Airway Epithelial Cells with Stimuli and Inhib-
itors. For inhibitory studies, cells were pretreated with inhibitors for 30 min before exposure to stimuli. In studies of PMA or HNE, the cells were treated with PMA (10 ng͞ml) or HNE (100 nM) for 1 h, washed three times with medium, and cultured with the same concentrations of inhibitors as in the pretreatment period. After 8 or 24 h, cell-culture supernatants and cell lysates were collected to analyze MUC5AC expression.
Cytotoxicity Detection and Measurement of Total Protein. Lactatedehydrogenase activity in supernatants of cell cultures treated with or without inhibitors was measured by using the Cytotoxicity Detection Kit (Roche Diagnostics). Total protein in cell lysates of cell cultures treated with or without inhibitors was 
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Mucin ELISA. Production of MUC5AC mucin protein in cell lysates and cell culture supernatants was measured by ELISA, as described in ref. 3 . The amount of MUC5AC mucin in each sample was normalized to total protein in cell lysate and was expressed as g of mucin per g of total cellular protein.
Effect of Stimuli on Cleavage and Release of Soluble TGF-␣. Cells were stimulated with or without PMA or HNE for 2 h. For inhibitory studies, cells were pretreated with inhibitors for 30 min before adding a stimulus. To prevent soluble TGF-␣ from binding to EGFR, an EGFR-neutralizing Ab (4 g/ml) was added 30 min before adding a stimulus. Cell supernatants were collected, and TGF-␣ was measured with the TGF-␣ ELISA kit (Oncogene Science).
Small Interfering RNA (siRNA) Preparation and Transfection of Cells
Predesigned human Duox1 siRNAs (nos. 24873 and 24969) were purchased from Ambion (Austin, TX). In our preliminary studies, only siRNA no. 24969 (100 nM) had a significant inhibitory effect on MUC5AC mucin production by PMA. Therefore, this siRNA was used for all studies. The 21-nt sequences of Duox1 (siRNA no. 24969) were (sense) GGACUUAUCCUGGCUAGAGtt and (antisense) CUCUAGCCAGGAUAAGUCCtg. Silencer Negative Control no. 1 siRNA (Ambion) was used as a nonspecific siRNA. SiRNA transfection into NCI-H292 cells was carried out by using Lipofectamine 2000 (Invitrogen). Specific silencing of Duox1 was confirmed by using real-time quantitative PCR at 72 h after transfection.
Preparation of Membrane Fraction and Western Blot Analysis.
Membrane fraction of cells was prepared according to the method described in ref. 14. Briefly, the cells were harvested and washed twice with PBS. The cell pellet was resuspended in relaxation buffer (100 mM KCl͞3 mM NaCl͞3.5 mM MgCl 2 ͞1 mM EGTA͞10 mM Hepes͞0.5 mM phenylmethylsulfonyl fluoride) and 1:100 dilution of proteinase inhibitors (Complete Mini, Roche), disrupted by two 10-s cycles of sonication on ice, and then centrifuged at 600 ϫ g for 10 min at 4°C to remove nuclei and unbroken cells. The supernatant was then ultracentrifuged at 100,000 ϫ g for 30 min at 4°C. The pellet was resuspended in relaxation buffer with vigorous mixing and again centrifuged at 100,000 ϫ g for 15 min at 4°C. The final pellet, representing the membrane fraction, was resuspended in relaxation buffer and subjected to Western blot analysis, as described in ref.
2.
Recombinant TACE Cleavage Assay. Purified recombinant TACE without the prodomain was purchased from Calbiochem. TACE inhibitory peptide (TIP) was synthesized from TACE prodomain sequence, PKVCGYLK (15), by BioSource International (Camarillo, CA). TACE activity was determined by continuous kinetic assays using the f luorogenic TACE substrate III, DABCYL-LAQAVRSSSR-EDANS (Calbiochem). The f luorescence intensity was monitored in a CytoFluor 2350 multiwell f luorescent plate reader (Applied Biosystems) by using wavelengths of 340 and 490 nm for excitation and emission, respectively. All reactions were initiated in 50 l of 50 mM Tricine buffer (pH 7.5) containing 100 mM NaCl, 10 mM CaCl 2 , and 1 mM ZnCl 2 . To inhibit TACE, TIP (400 M) was incubated with TACE (200 nM) for 1 h at 27°C. To test whether HNE can reverse TACE inhibition, HNE was added to the reactions (TACE plus TIP) for final concentrations of 10, 100, and 1,000 nM and incubated for 30 min. H 2 O 2 (4 mM), which has been reported to reverse TACE inhibition by TIP (16) , was used as a positive control. Finally, TACE substrate III was added to the reactions for a final concentration of 20 M, and the f luorescence intensity was monitored every 10 min for 6 h.
Statistical Analysis. Data are presented as mean Ϯ SD (n ϭ 3). ANOVA was used to determine statistically significant differences (P Ͻ 0.01).
Results

ROS Mediate PMA-Induced TGF-␣ Release and MUC5AC Expression.
PMA (10 ng͞ml) induced ROS production in both NHBE and NCI-H292 cells (Fig. 1A) . Pretreatment with ROS scavengers DMTU and nPG prevented PMA-induced TGF-␣ release (Fig.  1B) , MUC5AC gene expression (Fig. 1C) , and mucin protein production (Fig. 1D) , implicating ROS in TACE activation͞ TGF-␣ release and mucin expression by PMA in airway epithelial cells.
Epithelial NADPH Oxidase Generates ROS, Mediating TACE Activation
and Mucin Production by PMA. Pretreatment with a Nox inhibitor, DPI, prevented PMA-induced ROS generation ( Fig. 2A) , TGF-␣ release (Fig. 2B) , mucin gene expression (Fig. 2C) , and protein production (Fig. 2D) . To exclude the involvement of other oxidases, we investigated the effect of inhibitors of xan- thine oxidase (allopurinol, 100 M) and nitric oxide synthase (N G -monoethyl-L-arginine, 100 M). None of the inhibitors had a significant inhibitory effect on MUC5AC gene expression (Fig.  2C ) and protein production (Fig. 2D) (Fig. 3A) prevented ROS generation (Fig. 3B) , TGF-␣ release (Fig. 3C) , MUC5AC gene expression (Fig. 3D) , and protein production (Fig. 3E) by PMA. Transfection of negative control siRNA was without inhibitory effect (Fig. 3) . These results implicate Duox1 in PMA-induced responses.
PMA Activates Duox1 by Causing Assembly of the Cytosolic Compo-
nents of Nox with Duox1. Phagocytic Nox generates ROS when the cytosolic components (e.g., p47 phox and p67 phox ) move to the plasma membrane to form the complete enzyme Nox with gp91 phox (17) . We examined whether PMA causes Duox1 activation by means of a similar mechanism. PMA caused p47 phox and p67 phox translocation from cytosol to plasma membrane (Fig. 4A) . Pretreatment with apocynin, which blocks Nox assembly (18) , prevented translocation of p47 phox and p67 phox to the plasma membrane (Fig. 4A ), ROS generation (Fig. 4B) , TGF-␣ release (Fig. 4C) , mucin gene expression (Fig. 4D) , and protein production (Fig. 4E) . From these results, we conclude that PMA activates Duox1 by causing assembly of the cytosolic components with Duox1.
PKC Isoforms PKC␦ and PKC Mediate Duox1 Activation and Mucin
Expression by PMA. PMA exerts functions through activation of PKC. Two major groups of PKC isoforms exist: Ca 2ϩ -dependent PKCs including PKC␣, PKC␤, and PKC␥; and Ca 2ϩ -independent PKCs including PKC␦, PKC, and PKC. Pretreatment with the PKC␦͞ inhibitor rottlerin prevented ROS generation (Fig. 5A) , TGF-␣ release (Fig. 5B) , mucin gene expression (Fig. 5C) , and protein production (Fig. 5D) by PMA, whereas PKC␣͞␤ 1 inhibitor Gö 6976 did not inhibit PMAinduced effects (Fig. 5E , data shown for mucin protein production only). These results suggest that PKC␦͞ activates Duox1 to produce ROS, which activate TACE, leading to TGF-␣ release and mucin expression.
HNE Induces Mucin Expression via a Signaling Pathway Involving
PKC␦͞-Duox1-ROS-TACE. Having established the role of Duox1 in mucin expression by PMA, we examined whether this mechanism could be extended to HNE. First, we examined whether HNE has a direct action on TACE. Preincubation of TACE with TIP prevented cleavage of TACE substrate (Fig. 6A) . Exogenous H 2 O 2 (4 mM) reversed the TACE inhibition by TIP, implicating a direct action of ROS on TACE. However, various concentrations of HNE (10, 100, and 1,000 nM) failed to reverse the inhibitory effect of TIP on TACE, suggesting that there is no direct action of HNE on TACE. Second, we examined effects of PKC␦͞ inhibitor rottlerin or Nox inhibitors DPI and apocynin on HNE-induced responses. Pretreatment with these inhibitors prevented HNE-induced ROS generation (Fig. 6B) , TGF-␣ release (Fig. 6C) , mucin gene expression (Fig. 6D) , and mucin protein production (Fig. 6E) in both NHBE and NCI-H292 cells. Next, we confirmed the role of Duox1 in these responses to HNE by knocking down the expression of Duox1 with siRNA. Knockdown of Duox1 prevented all of these effects of HNE in NCI-H292 cells (Fig. 6 F-I) . Together, we conclude that HNE induces MUC5AC gene expression and protein production via a signaling pathway involving PKC␦͞-Duox1-ROS-TACE-TGF-␣ in human airway epithelial cells.
Discussion
Our previous studies showed that a TACE-EGFR cascade is a primary signaling pathway that regulates MUC5AC mucin expression in response to multiple stimuli in airway epithelial cells (2) (3) (4) . Here, we show that PMA and HNE activate Duox1 through PKC␦͞, which causes TACE activation by producing ROS, resulting in TGF-␣ release and mucin production. Thus, we have identified a signaling pathway mediating mucin production involving PKC␦͞-Duox1-ROS-TACE-pro-TGF-␣-EGFR-mitogen-activated protein kinase in airway epithelial cells (Fig. 7) .
The cellular process of TACE activation has not been defined. TACE is synthesized in a latent form with an inhibitory Nterminal prodomain masking the catalytic domain (19) . Schlondorff et al. (20) reported that the prodomain is cleaved at a furin site in a late Golgi compartment. Black et al. (19) reported that the cell-surface TACE is without a prodomain, suggesting that TACE releases its prodomain before reaching the cell-surface membranes. However, conflicting evidence also exists. Doedens et al. (21) showed that PMA increases TACE-specific peptide cleavage without altering TACE expression on cell-surface membrane (7-15 min after PMA stimulation), suggesting that the increased activity of TACE is not due to an increase in TACE abundance on the cell surface but to an unknown mechanism that causes TACE activation. In support of this speculation, Milla et al. (22) showed that the prodomain of TACE is essential for appropriate secretion and processing of TACE catalytic domain. Deletion of the prodomain appears to make the catalytic domain a target for intracellular degradation. Zhang et al. (16) showed that a peptide synthesized from TACE prodomain sequence can inhibit the activity of the recombinant active TACE, a finding that was confirmed in the present study. Moreover, this TACE inhibition can be reversed by treatment with exogenous ROS. Thus, the cellular process controlling the removal of TACE prodomain and TACE activation appears more complicated than previously conceived. We propose a two-step posttranslational processing mechanism for TACE activation.
1. Cleavage of TACE prodomain at a furin site occurs in a late Golgi compartment. The cleaved prodomain is associated with the catalytic domain via an intramolecular bond between the cysteine residue in the prodomain and the zinc atom in the catalytic domain (16) . Processed TACE molecules are transported to cell-surface membranes. 2. Upon cellular stimulation, the cysteine-zinc bond breaks, the prodomain is released, and the catalytic domain is exposed.
In PMA-and HNE-stimulated cases, cells generate ROS (e.g., H 2 O 2 ), which attack the cysteine sulfhydryl moiety and release it from coordination with the catalytic zinc, thus activating TACE.
The identification of Nox homologues in epithelial tissues such as bronchial epithelium (e.g., Duox1) implies that the generation of ROS in these tissues is a fine-tuned biological strategy. Three hypotheses concerning the function of ROS generated by Nox͞ Duox have been proposed: (i) role of host defense in killing invading microbes and cancer cells, (ii) role in signal transduction, and (iii) role in metabolism. In the present study, we focused on the role of ROS in TACE activation. Here, we found that Duox1 activated by PMA and HNE produces ROS, which activate TACE, resulting in TGF-␣ release and mucin production in airway epithelial cells. Because TACE cleaves many substrates (e.g., TNF-␣, TNF receptors, TGF-␣, amphiregulin, and L-selectin), the identification of TACE activation by Duox1 may have broad implications concerning the understanding of both physiological and pathophysiological processes in cells.
Nox has been studied extensively in phagocytes (23, 24) . The phagocytic Nox consists of a membrane-bound cytochrome, b 558 ; a complex of gp91 phox and p22 phox ; and four cytosolic components, p47 phox , p67 phox , p40 phox , and Rac1͞2 (7). Sixtransmembrane gp91 phox is the catalytic core of Nox. Nox homologues in noninflammatory cells include Nox1 through Nox5 (25, 26) and Duox1͞2 (9) . Duox1 is expressed in bronchial epithelium (10) . In airways, Duox1 was recently reported to provide H 2 O 2 for lactoperoxidase-catalyzed reactions in antimicrobial activity (10) . To explore the role of Duox1 in the signaling pathway mediating TACE activation and mucin production, we knocked down the expression of Duox1 with siRNA: Knockdown of Duox1 prevented PMA-and HNE-induced effects, implicating Duox1 in TACE activation and mucin expression.
HNE is present in the airway secretions of patients with chronic inflammatory airway diseases. HNE plays an important role in mucus hypersecretion. Thus, Kohri et al. (13) showed that HNE induces MUC5AC expression by increasing the release of soluble TGF-␣. Fisher et al. (27) reported that ROS are involved in HNE-induced MUC5AC gene expression. Aoshiba et al. (28) showed that HNE induces ROS generation in NHBE cells. However, the mechanisms by which HNE induces ROS and TGF-␣ shedding were unknown. In the present study, we show that HNE induces H 2 O 2 production, TACE activation͞TGF-␣ shedding, and mucin expression via a signaling pathway involving PKC␦͞PKC and Duox1 in human airway epithelial cells.
MUC5AC mucin is a large glycoprotein with a number of carbohydrate chains attached to the core protein moiety. Both the protein backbones and the carbohydrates contribute to the viscoelastic properties of airway mucus. Thus, understanding of the signaling pathway regulating mucin expression reveals only one facet in the puzzle of mucus hypersecretion. Further investigation concerning mechanisms such as those regulating mucin glycosylation is needed to uncover the complex picture of mucus hypersecretion.
In summary, we show that PMA and HNE induce mucin expression in human airway epithelial cells via a signaling pathway involving PKC␦͞-Duox1-ROS-TACE. These findings are especially important because HNE is implicated in mucus hypersecretion associated with chronic inflammatory airway diseases. The discovery that Duox1 is involved in mucin induction suggests new therapies for hypersecretory airway diseases.
